Eight years after little Affimed was founded in Germany, it’s become the new Cinderella of the global biotech scene, with Genentech playing the role of Prince Charming — offering the keys to the kingdom and a glass R&D slipper that seems to fit just right. The little German biotech Affimed $AFMD has snagged a $96 … Continue reading The new Cinderella story: Cancer powerhouse Genentech lines up an NK alliance with Affimed loaded with billions in biobucks